发明申请
US20130052187A1 Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions
审中-公开
针对丙型肝炎病毒E1E2复合物的抗体，HCV颗粒的组合物和药物组合物
- 专利标题： Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions
- 专利标题（中）： 针对丙型肝炎病毒E1E2复合物的抗体，HCV颗粒的组合物和药物组合物
-
申请号： US13616665申请日： 2012-09-14
-
公开(公告)号： US20130052187A1公开(公告)日： 2013-02-28
- 发明人: Marie Anne PETIT , Emmanuel DROUET , Christian TREPO
- 申请人： Marie Anne PETIT , Emmanuel DROUET , Christian TREPO
- 申请人地址： FR Paris FR Grenoble Cedex FR Marcy -L-Etoile
- 专利权人： INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),Universite Joseph Fourier (Grenoble),BIOMERIEUX SA
- 当前专利权人： INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),Universite Joseph Fourier (Grenoble),BIOMERIEUX SA
- 当前专利权人地址： FR Paris FR Grenoble Cedex FR Marcy -L-Etoile
- 优先权： EP03290822.0 20030401
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/46 ; C12N15/13 ; C12N5/18 ; C12N5/10 ; A61P31/14 ; C12N5/12 ; C07K16/00 ; C12N15/63
摘要：
New conformational antibodies, and more particular conformational monoclonal antibodies and fragments thereof, are directed against HCV. Also provided are compositions of particles that are recognized by such antibodies, and pharmaceutical compositions containing these particles. Also described are HCV enveloped subviral particles and purified HCV enveloped complete viral particles, as well as processes for their preparation.
信息查询
